Skip to main navigation Skip to search Skip to main content

Phenotypic and genotypic correlates of the sodium bicarbonate-responsive phenotype among methicillin-resistant Staphylococcus aureus isolates from skin and soft-tissue infections

  • Selvi C. Ersoy
  • , Sabrina L. Madrigal
  • , Liang Chen
  • , Jose Mediavilla
  • , Barry Kreiswirth
  • , Evelyn A. Flores
  • , Loren G. Miller
  • , Yan Q. Xiong
  • , Ewan M. Harrison
  • , Beth Blane
  • , Sharon J. Peacock
  • , Robin Patel
  • , Henry F. Chambers
  • , Arnold S. Bayer
  • , Richard A. Proctor
  • University of California at Los Angeles
  • California State University Los Angeles
  • Hackensack Meridian Health
  • Wellcome Trust Sanger Institute
  • University of Cambridge
  • London School of Hygiene and Tropical Medicine
  • Mayo Clinic Rochester, MN
  • University of California at San Francisco
  • University of Wisconsin-Madison

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

Objectives: The objective of this study is to assess the frequency of the novel sodium bicarbonate (NaHCO3)-responsive phenotype, wherein clinical methicillin-resistant Staphylococcus aureus (MRSA) isolates are rendered susceptible to standard-of-care β-lactams in the presence of NaHCO3, in a collection of 103 clinical U.S. MRSA skin and soft-tissue infection (SSTI) isolates and 22 clinical European SSTI isolates. This study determined the correlation between specific phenotypic and genotypic metrics and the NaHCO3-responsive phenotype among U.S. SSTI isolates. Methods: Antimicrobial susceptibility testing was performed to determine susceptibility phenotypes. Targeted and whole-genome sequencing with a genome-wide sequence analysis were conducted to identify specific and novel genotypes of interest that may be associated with the NaHCO3-responsive phenotype. Gene expression analysis and targeted gene deletion were performed to assess the role of a specific novel genetic locus in the NaHCO3-responsive phenotype. Results: The NaHCO3-responsive phenotype was identified in 78/103 U.S. isolates and 4/22 UK isolates to cefazolin (CFZ), and in 17/103 U.S. isolates and 1/22 UK isolates to oxacillin. In U.S. isolates, a significant association was identified between NaHCO3-responsiveness to CFZ and: (a) susceptibility to amoxicillin–clavulanate; (b) a specific mecA genotype; (c) clonal complex type 8; and (d) spa type t008. Genome-wide sequence analysis identified single nucleotide polymorphisms (SNPs) in an AraC family regulator (SAUSA300_RS00540) to be exclusively found in NaHCO3-non-responsive SSTI strains. In vitro HCO3 exposures of NaHCO3-responsive strains, but not -non-responsive strains, caused >2-fold upregulated expression of this gene. Deletion of this gene rendered NaHCO3-responsive strain MRSA 11/11 no longer NaHCO3-responsive to CFZ; we have termed this gene the staphylococcal AraC bicarbonate-response regulator. Discussion: NaHCO3-responsiveness is highly associated with clonal complex type 8/spa type t008, a commonly circulating genetic background in North America. The AraC bicarbonate-response regulator, staphylococcal AraC bicarbonate-response regulator, appears to be associated with the mechanism of NaHCO3-responsiveness, but more work is needed to verify.

Original languageEnglish
Pages (from-to)588-593
Number of pages6
JournalClinical Microbiology and Infection
Volume31
Issue number4
DOIs
StatePublished - Apr 2025

Keywords

  • Methicillin-resistant Staphylococcus aureus (MRSA)
  • NaHCO-Responsive
  • Skin and soft-tissue infection (SSTI)
  • Sodium bicarbonate (NaHCO)
  • sabR
  • β-lactams

Fingerprint

Dive into the research topics of 'Phenotypic and genotypic correlates of the sodium bicarbonate-responsive phenotype among methicillin-resistant Staphylococcus aureus isolates from skin and soft-tissue infections'. Together they form a unique fingerprint.

Cite this